(Total Views: 78)
Posted On: 12/22/2020 8:05:47 AM
Post# of 124739
$CYDY News Article - FDA Resumes eIND Approval for Severe-to-Critical COVID-19 Patients Use of Vyrologix(TM) (leronlimab) Following Full Enrollment in CytoDyn's Phase 3 Trial https://marketwirenews.com/news-releases/fda-...02452.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
